-+ 0.00%
-+ 0.00%
-+ 0.00%

Revelation Biosciences Q4 EPS $(1.65) Misses $(0.96) Estimate

Benzinga·02/26/2026 21:49:55
Listen to the news
Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(1.65) per share which missed the analyst consensus estimate of $(0.96) by 71.88 percent. This is a 97.24 percent increase over losses of $(59.76) per share from the same period last year.